Realta Life Sciences
View On Demand

Saving The Lives and Brains of Newborn Babies

About the Event

Nearly once every hour in the U.S., an infant is born with brain damage due to Hypoxic Ischemic Encephalopathy (HIE). HIE is responsible for 23% of infant deaths world-wide and results from lack of oxygen and blood rushing back to the brain causing severe inflammation.

ReAlta Life Sciences has developed RLS-0071, a treatment that dramatically improves outcomes for babies effected by HIE. In vitro, ex vivo, and animal tests show RLS-0071 decreases the area of brain tissue injury by 50% and dramatically improves neuro-cognitive outcomes.

The results are so promising the company has received Pediatric Orphan Drug designation from the FDA.

Join our webinar with ReAlta CEO, Ulrich Thienel, MD, to hear why babies once destined to be wheelchair bound for life will be able to walk and infants who may have died from HIE can not only survive, but also thrive.

View On-Demand


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.